Co-Diagnostics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Co-Diagnostics, Inc. (CODX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $67.52 per share as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $67.52.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $73.57.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $68.91.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $2.26.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2026-06-30 | $67.52 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $73.57 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $68.91 10-K · filed 2026-03-31 | |
| 2025-09-30 | $2.26 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $2.26 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.26 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $2.19 10-K · filed 2025-03-27 | |
| 2024-09-30 | $2.19 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $2.19 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $2.19 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $2.19 10-K · filed 2024-03-14 | |
| 2023-09-30 | $2.19 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.19 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.19 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $2.19 10-K · filed 2023-03-16 | |
| 2022-09-30 | $2.19 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $2.19 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $2.05 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.01 10-K · filed 2022-03-24 | |
| 2021-09-30 | $2.01 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $2.20 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $2.20 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $2.26 10-Q · filed 2021-05-13 | $2.32 10-K · filed 2021-03-25 |
| 2020-09-30 | $1.74 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $1.53 10-Q/A · filed 2020-11-03 | |
| 2019-12-31 | $1.68 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |